 |
Autologous CD4+ and CD8+ T cells expressing a CD19-specific chimeric antigen receptor |
|---|---|
| Trade Name | |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| EU Market Approval | EU |
| EU Designation Date | 2017-07-17 00:00:00 |
| Sponsor | Celgene Europe Limited |
| |
Autologous CD4+ and CD8+ T cells expressing a CD19-specific chimeric antigen receptor |
|---|---|
| Trade Name | |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| EU Market Approval | EU |
| EU Designation Date | 2017-07-17 00:00:00 |
| Sponsor | Celgene Europe Limited |